MetaVia Inc. — Director's Dealing 2020

Jan 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeuroBo Pharmaceuticals, Inc. (NRBO)
CIK: 0001638287
Period of Report: 2020-01-13

Reporting Person: Salsbury Michael (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-13	Non-qualified stock option (right to buy)	$8.39	A	60000	Acquired	2030-01-12	Common Stock (60000)	Direct

Footnotes

F1: The option vests in 36 equal monthly installments beginning on 2/13/2020, such that the option will be fully vested on the third anniversary of the date of grant.